Serum	0	5	B-Organism_substance
and	6	9	O
urine	10	15	B-Organism_substance
levels	16	22	O
of	23	25	O
interleukin	26	37	B-Gene_or_gene_product
-	37	38	I-Gene_or_gene_product
8	38	39	I-Gene_or_gene_product
in	40	42	O
patients	43	51	B-Organism
with	52	56	O
non	57	60	B-Pathological_formation
-	60	61	I-Pathological_formation
Hodgkin	61	68	I-Pathological_formation
'	68	69	I-Pathological_formation
s	69	70	I-Pathological_formation
lymphoma	71	79	I-Pathological_formation
.	79	80	O

Angiogenesis	82	94	O
plays	95	100	O
an	101	103	O
important	104	113	O
role	114	118	O
in	119	121	O
many	122	126	O
types	127	132	O
of	133	135	O
cancer	136	142	B-Pathological_formation
.	142	143	O

Interleukin	144	155	B-Gene_or_gene_product
-	155	156	I-Gene_or_gene_product
8	156	157	I-Gene_or_gene_product
(	158	159	O
IL	159	161	B-Gene_or_gene_product
-	161	162	I-Gene_or_gene_product
8	162	163	I-Gene_or_gene_product
)	163	164	O
is	165	167	O
known	168	173	O
to	174	176	O
be	177	179	O
a	180	181	O
pro	182	185	O
-	185	186	O
inflammatory	186	198	O
and	199	202	O
pro	203	206	O
-	206	207	O
angiogenic	207	217	O
cytokine	218	226	O
,	226	227	O
and	228	231	O
IL	232	234	B-Gene_or_gene_product
-	234	235	I-Gene_or_gene_product
8	235	236	I-Gene_or_gene_product
has	237	240	O
been	241	245	O
reported	246	254	O
to	255	257	O
be	258	260	O
associated	261	271	O
with	272	276	O
tumor	277	282	B-Pathological_formation
progression	283	294	O
,	294	295	O
prognosis	296	305	O
and	306	309	O
survival	310	318	O
in	319	321	O
several	322	329	O
types	330	335	O
of	336	338	O
cancers	339	346	B-Pathological_formation
.	346	347	O

However	348	355	O
,	355	356	O
the	357	360	O
role	361	365	O
of	366	368	O
IL	369	371	B-Gene_or_gene_product
-	371	372	I-Gene_or_gene_product
8	372	373	I-Gene_or_gene_product
in	374	376	O
non	377	380	B-Pathological_formation
-	380	381	I-Pathological_formation
Hodgkin	381	388	I-Pathological_formation
'	388	389	I-Pathological_formation
s	389	390	I-Pathological_formation
lymphoma	391	399	I-Pathological_formation
(	400	401	O
NHL	401	404	B-Pathological_formation
)	404	405	O
has	406	409	O
not	410	413	O
been	414	418	O
fully	419	424	O
determined	425	435	O
.	435	436	O

Here	437	441	O
,	441	442	O
we	443	445	O
evaluated	446	455	O
the	456	459	O
usefulness	460	470	O
of	471	473	O
measuring	474	483	O
serum	484	489	B-Organism_substance
and	490	493	O
urine	494	499	B-Organism_substance
IL	500	502	B-Gene_or_gene_product
-	502	503	I-Gene_or_gene_product
8	503	504	I-Gene_or_gene_product
levels	505	511	O
in	512	514	O
patients	515	523	B-Organism
with	524	528	O
NHL	529	532	B-Pathological_formation
.	532	533	O

We	534	536	O
developed	537	546	O
reference	547	556	O
intervals	557	566	O
for	567	570	O
serum	571	576	B-Organism_substance
and	577	580	O
urine	581	586	B-Organism_substance
IL	587	589	B-Gene_or_gene_product
-	589	590	I-Gene_or_gene_product
8	590	591	I-Gene_or_gene_product
level	592	597	O
in	598	600	O
131	601	604	O
control	605	612	O
individuals	613	624	O
.	624	625	O

We	626	628	O
measured	629	637	O
serum	638	643	B-Organism_substance
IL	644	646	B-Gene_or_gene_product
-	646	647	I-Gene_or_gene_product
8	647	648	I-Gene_or_gene_product
and	649	652	O
urine	653	658	B-Organism_substance
IL	659	661	B-Gene_or_gene_product
-	661	662	I-Gene_or_gene_product
8	662	663	I-Gene_or_gene_product
levels	664	670	O
in	671	673	O
patients	674	682	B-Organism
with	683	687	O
NHL	688	691	B-Pathological_formation
,	691	692	O
and	693	696	O
we	697	699	O
compared	700	708	O
the	709	712	O
concentrations	713	727	O
with	728	732	O
those	733	738	O
of	739	741	O
control	742	749	O
individuals	750	761	O
.	761	762	O

The	763	766	O
reference	767	776	O
intervals	777	786	O
for	787	790	O
serum	791	796	B-Organism_substance
IL	797	799	B-Gene_or_gene_product
-	799	800	I-Gene_or_gene_product
8	800	801	I-Gene_or_gene_product
and	802	805	O
urine	806	811	B-Organism_substance
IL	812	814	B-Gene_or_gene_product
-	814	815	I-Gene_or_gene_product
8	815	816	I-Gene_or_gene_product
corrected	817	826	O
by	827	829	O
creatinine	830	840	B-Drug_or_compound
(	841	842	O
Cr	842	844	B-Drug_or_compound
)	844	845	O
were	846	850	O
15	851	853	O
.	853	854	O
9	854	855	O
-	855	856	O
430	856	859	O
.	859	860	O
3	860	861	O
pg	862	864	O
/	864	865	O
mL	865	867	O
and	868	871	O
0	872	873	O
.	873	874	O
0	874	875	O
-	875	876	O
28	876	878	O
.	878	879	O
4	879	880	O
pg	881	883	O
/	883	884	O
mg	884	886	O
Cr	887	889	B-Drug_or_compound
,	889	890	O
respectively	891	903	O
.	903	904	O

The	905	908	O
concentrations	909	923	O
of	924	926	O
urine	927	932	B-Organism_substance
IL	933	935	B-Gene_or_gene_product
-	935	936	I-Gene_or_gene_product
8	936	937	I-Gene_or_gene_product
/	937	938	O
Cr	938	940	B-Drug_or_compound
were	941	945	O
significantly	946	959	O
higher	960	966	O
in	967	969	O
patients	970	978	B-Organism
than	979	983	O
in	984	986	O
controls	987	995	O
(	996	997	O
48	997	999	O
.	999	1000	O
9	1000	1001	O
+	1001	1002	O
/	1002	1003	O
-	1003	1004	O
194	1004	1007	O
.	1007	1008	O
4	1008	1009	O
vs	1010	1012	O
.	1012	1013	O
5	1014	1015	O
.	1015	1016	O
2	1016	1017	O
+	1017	1018	O
/	1018	1019	O
-	1019	1020	O
13	1020	1022	O
.	1022	1023	O
8	1023	1024	O
pg	1025	1027	O
/	1027	1028	O
mg	1028	1030	O
Cr	1031	1033	B-Drug_or_compound
,	1033	1034	O
P	1035	1036	O
less	1037	1041	O
than	1042	1046	O
0	1047	1048	O
.	1048	1049	O
001	1049	1052	O
)	1052	1053	O
.	1053	1054	O

However	1055	1062	O
,	1062	1063	O
there	1064	1069	O
were	1070	1074	O
no	1075	1077	O
significant	1078	1089	O
differences	1090	1101	O
in	1102	1104	O
serum	1105	1110	B-Organism_substance
IL	1111	1113	B-Gene_or_gene_product
-	1113	1114	I-Gene_or_gene_product
8	1114	1115	I-Gene_or_gene_product
concentrations	1116	1130	O
between	1131	1138	O
NHL	1139	1142	B-Pathological_formation
patients	1143	1151	B-Organism
and	1152	1155	O
controls	1156	1164	O
(	1165	1166	O
159	1166	1169	O
.	1169	1170	O
2	1170	1171	O
+	1171	1172	O
/	1172	1173	O
-	1173	1174	O
40	1174	1176	O
.	1176	1177	O
4	1177	1178	O
vs	1179	1181	O
.	1181	1182	O
99	1183	1185	O
.	1185	1186	O
6	1186	1187	O
+	1187	1188	O
/	1188	1189	O
-	1189	1190	O
107	1190	1193	O
.	1193	1194	O
1	1194	1195	O
pg	1196	1198	O
/	1198	1199	O
mL	1199	1201	O
;	1201	1202	O
P	1203	1204	O
=	1204	1205	O
0	1205	1206	O
.	1206	1207	O
099	1207	1210	O
)	1210	1211	O
.	1211	1212	O

Receiver	1213	1221	O
operating	1222	1231	O
characteristic	1232	1246	O
(	1247	1248	O
ROC	1248	1251	O
)	1251	1252	O
analysis	1253	1261	O
gave	1262	1266	O
0	1267	1268	O
.	1268	1269	O
83	1269	1271	O
and	1272	1275	O
0	1276	1277	O
.	1277	1278	O
43	1278	1280	O
ROC	1281	1284	O
area	1285	1289	O
values	1290	1296	O
for	1297	1300	O
urine	1301	1306	B-Organism_substance
IL	1307	1309	B-Gene_or_gene_product
-	1309	1310	I-Gene_or_gene_product
8	1310	1311	I-Gene_or_gene_product
/	1311	1312	O
Cr	1312	1314	B-Drug_or_compound
and	1315	1318	O
serum	1319	1324	B-Organism_substance
IL	1325	1327	B-Gene_or_gene_product
-	1327	1328	I-Gene_or_gene_product
8	1328	1329	I-Gene_or_gene_product
,	1329	1330	O
respectively	1331	1343	O
.	1343	1344	O

There	1345	1350	O
was	1351	1354	O
no	1355	1357	O
correlation	1358	1369	O
between	1370	1377	O
the	1378	1381	O
serum	1382	1387	B-Organism_substance
and	1388	1391	O
urine	1392	1397	B-Organism_substance
concentrations	1398	1412	O
of	1413	1415	O
IL	1416	1418	B-Gene_or_gene_product
-	1418	1419	I-Gene_or_gene_product
8	1419	1420	I-Gene_or_gene_product
and	1421	1424	O
clinical	1425	1433	O
variables	1434	1443	O
,	1443	1444	O
the	1445	1448	O
only	1449	1453	O
exception	1454	1463	O
being	1464	1469	O
the	1470	1473	O
international	1474	1487	O
prognostic	1488	1498	O
index	1499	1504	O
(	1505	1506	O
IPI	1506	1509	O
)	1509	1510	O
,	1510	1511	O
which	1512	1517	O
showed	1518	1524	O
a	1525	1526	O
marginal	1527	1535	O
correlation	1536	1547	O
with	1548	1552	O
urine	1553	1558	B-Organism_substance
IL	1559	1561	B-Gene_or_gene_product
-	1561	1562	I-Gene_or_gene_product
8	1562	1563	I-Gene_or_gene_product
/	1563	1564	O
Cr	1564	1566	B-Drug_or_compound
levels	1567	1573	O
(	1574	1575	O
P	1575	1576	O
=	1576	1577	O
0	1577	1578	O
.	1578	1579	O
07	1579	1581	O
)	1581	1582	O
.	1582	1583	O

This	1584	1588	O
study	1589	1594	O
indicated	1595	1604	O
that	1605	1609	O
urine	1610	1615	B-Organism_substance
IL	1616	1618	B-Gene_or_gene_product
-	1618	1619	I-Gene_or_gene_product
8	1619	1620	I-Gene_or_gene_product
/	1620	1621	O
Cr	1621	1623	B-Drug_or_compound
levels	1624	1630	O
might	1631	1636	O
be	1637	1639	O
useful	1640	1646	O
as	1647	1649	O
a	1650	1651	O
diagnostic	1652	1662	O
marker	1663	1669	O
of	1670	1672	O
NHL	1673	1676	B-Pathological_formation
.	1676	1677	O

